review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Wadie F Bahou | |
Dmitri V Gnatenko | |||
Lisa Senzel | |||
P2860 | cites work | Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins | Q28188035 |
Moderation of the platelet releasate response by aspirin | Q28219081 | ||
Reactome: a knowledge base of biologic pathways and processes | Q28757721 | ||
Human Protein Reference Database--2009 update | Q29547392 | ||
The minimum information about a proteomics experiment (MIAPE) | Q29615391 | ||
Modifications of blood platelet proteins of patients with schizophrenia. | Q30375094 | ||
The platelet microparticle proteome | Q30438273 | ||
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions | Q33195220 | ||
The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile | Q33220140 | ||
Comparative RNA expression analyses from small-scale, single-donor platelet samples. | Q33231923 | ||
A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein | Q33267507 | ||
Mass spectrometry-based functional proteomics: from molecular machines to protein networks | Q33300676 | ||
Platelet-associated PF-4 as a biomarker of early tumor growth | Q33301427 | ||
Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries | Q33301722 | ||
Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis | Q33301724 | ||
Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome | Q33317316 | ||
Platelets actively sequester angiogenesis regulators | Q33387520 | ||
Comparison of human platelet membrane-cytoskeletal proteins with the plasma proteome: Towards understanding the platelet-plasma nexus. | Q33764382 | ||
Protein synthesis by platelets: historical and new perspectives | Q34522274 | ||
Phosphoproteome of resting human platelets | Q34726895 | ||
Proteomic approaches to dissect platelet function: Half the story | Q35848791 | ||
Using proteomics to identify potential therapeutic targets in platelets. | Q36078636 | ||
Proteome analysis of signaling cascades in human platelets. | Q36400131 | ||
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications | Q36644478 | ||
Proteomic analysis of platelet alpha-granules using mass spectrometry | Q36920727 | ||
Platelet activation and atherothrombosis | Q37031278 | ||
Transcript profiling of human platelets using microarray and serial analysis of gene expression (SAGE). | Q37288502 | ||
Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation | Q38327516 | ||
Proteomics of the TRAP-induced platelet releasate | Q38511589 | ||
Biological variation of the platelet proteome in the elderly population and its implication for biomarker research | Q40160272 | ||
Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients | Q42784830 | ||
Activity profiling of platelets by chemical proteomics. | Q46216829 | ||
The value of proteomics for the diagnosis of a platelet-related bleeding disorder. | Q46367580 | ||
MudPIT: multidimensional protein identification technology. | Q48031136 | ||
Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. | Q50675488 | ||
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles | Q56883405 | ||
Platelet Protein Interactions | Q56993688 | ||
The Human Platelet Membrane Proteome Reveals Several New Potential Membrane Proteins | Q57842292 | ||
Profiling of alterations in platelet proteins during storage of platelet concentrates | Q59566913 | ||
Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches | Q80166149 | ||
Proteomics: moving from a discovery to a quality assurance tool | Q80779868 | ||
P433 | issue | 5 | |
P304 | page(s) | 329-333 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | Current Opinion in Hematology | Q15757961 |
P1476 | title | The platelet proteome | |
P478 | volume | 16 |
Q58762162 | 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures |
Q36395085 | Alloantibody induced platelet responses in transplants: potent mediators in small packages |
Q38526268 | Application of Platelet-Rich Plasma to Disorders of the Knee Joint |
Q58723469 | Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis |
Q64058772 | Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review |
Q38846505 | Autologous Platelet-Rich Plasma for the Treatment of Pattern Hair Loss |
Q37047000 | Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement |
Q35796683 | Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies |
Q90353734 | Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer |
Q37435694 | Clinical marker of platelet hyperreactivity in diabetes mellitus |
Q92808421 | Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis |
Q33589680 | Creation of a federated database of blood proteins: a powerful new tool for finding and characterizing biomarkers in serum |
Q37719648 | De novo protein synthesis in mature platelets: a consideration for transfusion medicine |
Q36125605 | Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies - a randomized prospective controlled clinical trial. |
Q38649356 | Erythrocyte and platelet proteomics in hematological disorders |
Q38063574 | Exoproteomics: exploring the world around biological systems |
Q38620035 | Growth Factor Release from Lyophilized Porcine Platelet-Rich Plasma: Quantitative Analysis and Implications for Clinical Applications |
Q54469238 | Growth factor and proteinase profile of Vivostat® platelet-rich fibrin linked to tissue repair. |
Q60925160 | Human Platelet Protein Ubiquitylation and Changes following GPVI Activation |
Q33434452 | IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study |
Q57132246 | Immunological aspects of atherosclerosis: Figure 1 |
Q37058070 | In vitro study of the role of thrombin in platelet rich plasma (PRP) preparation: utility for gel formation and impact in growth factors release |
Q41907202 | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study. |
Q34306349 | Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma |
Q38803630 | Medicinal Plants with Antiplatelet Activity. |
Q48133074 | Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer. |
Q37660674 | Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. |
Q93004187 | Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center |
Q27004486 | Obstacles in haemocompatibility testing |
Q48301241 | Optimized human platelet lysate as novel basis for a serum-, xeno-, and additive-free corneal endothelial cell and tissue culture. |
Q47138311 | Optimized plasma preparation is essential to monitor platelet-stored molecules in humans |
Q39360814 | Platelet Derived Biomaterials for Therapeutic Use: Review of Technical Aspects |
Q38523001 | Platelet and red blood cell interactions and their role in rheumatoid arthritis. |
Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
Q48222655 | Platelet protein biomarker panel for ovarian cancer diagnosis |
Q52914539 | Platelet proteomics in thalassemia: Factors responsible for hypercoagulation. |
Q36509648 | Platelet secretion is kinetically heterogeneous in an agonist-responsive manner |
Q41463580 | Platelet-Rich Plasma as an Autologous and Proangiogenic Cell Delivery System |
Q64953898 | Platelet-rich fibrin increases the osteoprotegerin/receptor activator of nuclear factor-κB ligand ratio in osteoblasts. |
Q91949760 | Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol |
Q36997844 | Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. |
Q38101678 | Platelets and autoimmunity. |
Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
Q97544595 | Platelets can reflect the severity of Crohn's disease without the effect of anemia |
Q41208347 | Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. |
Q37820880 | Platelets: versatile modifiers of innate and adaptive immune responses to transplants |
Q93061899 | Polymers in Cartilage Defect Repair of the Knee: Current Status and Future Prospects |
Q38206848 | Primary haemostasis: newer insights. |
Q35581934 | Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study |
Q37716591 | Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer |
Q64228073 | Prognostic value of mean platelet volume to plateletcrit ratio in patients with osteosarcoma |
Q36650991 | Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis |
Q41266897 | Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. |
Q38505832 | Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study |
Q38504408 | Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study |
Q37956664 | Proteomics of blood and derived products: what's next? |
Q53175254 | Quantification of platelets and platelet derived growth factors from platelet-rich-plasma (PRP) prepared at different centrifugal force (g) and time. |
Q38034137 | Recent advances in proteomic technologies applied to cardiovascular disease. |
Q84725488 | Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease |
Q57495693 | Review: Proposed Methods to Improve the Survival of Adipose Tissue in Autologous Fat Grafting |
Q50246351 | Simplified platelet sample preparation for SDS-PAGE-based proteomic studies. |
Q33615612 | Slowed decay of mRNAs enhances platelet specific translation |
Q35077923 | Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference |
Q36735778 | Suppressive effect of exogenous carbon monoxide on endotoxin-stimulated platelet over-activation via the glycoprotein-mediated PI3K-Akt-GSK3β pathway |
Q52980361 | The effect of leukocyte-reduced platelet-rich plasma on the proliferation of autologous adipose-tissue derived mesenchymal stem cells. |
Q38213187 | The role of P2Y₁₂ receptor and activated platelets during inflammation |
Q35209331 | The role of growth factors in cartilage repair |
Q89848496 | The use of concentrated growth factor in dental implantology: A systematic review |
Q34889195 | Thrombin drives tumorigenesis in colitis-associated colon cancer |
Q35493448 | Thrombocytosis after hip and knee surgery in the rehabilitation setting: is it an occasional phenomenon? Relationship with deep venous thrombosis and functional outcome |
Q93367533 | Wound Healing: A Cellular Perspective |
Q83797482 | [Proteomics and transfusion medicine] |
Search more.